Pridopidine, a clinic‐ready compound, reduces 3,4‐dihydroxyphenylalanine‐induced dyskinesia in…

ABSTRACT Background Pridopidine, in development for Huntington's disease, may modulate aberrant l‐dopa‐induced effects including l‐dopa‐induced dyskinesia (LID). Objective This study investigated whether pridopidine could reduce LID in…

Unraveling gut microbiota in Parkinson’s disease and atypical parkinsonism

ABSTRACT Background: Although several studies have suggested that abnormalities in gut microbiota may play a critical role in the pathogenesis of PD, data are still extremely heterogeneous. Methods: 16S gene ribosomal RNA sequencing was…